Pfizer stock gains as Q1 profit rises 6.6 percent

Published on 09/24/2026 at 15:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pfizer stock traded at INR 4,046.20 on September 24, 2026, after a higher-profit quarter. Q1 revenue reached INR 653.17 crore, while the Minipress XL decision adds a strategic shift.

Pfizer, INE182A01018, Illustration mit AI erstellt.

Pfizer Limited stock (ISIN INE182A01018) gained 0.51 percent to INR 4,046.20 on the NSE on September 24, 2026. The move followed a Q1 FY27 report showing higher revenue and profit, while the discontinuation of Minipress XL adds a separate business consideration.

Q1 revenue reaches INR 653.17 crore

According to Sahi, Pfizer Limited reported Q1 FY27 operating revenue of INR 653.17 crore, up 8.3 percent from INR 603.05 crore in Q1 FY26. The comparison points to continued top-line expansion despite the stock trading close to its yearly low.

The same Q1 FY27 report put standalone net profit at INR 204.47 crore, an increase of 6.6 percent from INR 191.75 crore a year earlier. Profit growth therefore trailed revenue growth by 1.7 percentage points, a useful margin signal for the next quarterly update.

Minipress XL changes the mix

BusinessToday reported that Pfizer Limited stopped marketing, distributing, and selling Minipress XL in India after Pfizer Inc. discontinued manufacturing the product. The report said the Indian company would receive INR 131.38 crore under the arrangement.

That payment is distinct from recurring operating revenue and should not be treated as a substitute for product sales. For investors, the key issue is how the company replaces the product contribution after the one-time inflow and whether the Q1 revenue pace continues.

Stock remains below its yearly high

Pfizer stock stood 27.47 percent below its 52-week high of INR 5,578.50 and 2.29 percent above its 52-week low of INR 3,955.50 on September 24, 2026. The market capitalization was INR 185,104,473,218 on the same date.

Pfizer stock at INR 4,046.20

Pfizer stock stood at INR 4,046.20 on the NSE on September 24, 2026, up 0.51 percent for the session. The combination of Q1 growth, the Minipress XL transition, and the distance from the 52-week high defines the current trading picture.